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A method is proposed that incorporates the effects of intratreatment organ motion due to breathing
on the dose calculations for the treatment of liver disease. Our method is based on the convolution
of a static dose distribution with a probability distribution function ~PDF! which describes the
nature of the motion. The organ motion due to breathing is assumed here to be one-dimensional ~in
the superior–inferior direction!, and is modeled using a periodic but asymmetric function ~more
time spent at exhale versus inhale!. The dose distribution calculated using convolution-based meth-
ods is compared to the static dose distribution using dose difference displays and the effective
volume (Veff) of the uninvolved liver, as per a liver dose escalation protocol in use at our institu-
tion. The convolution-based calculation is also compared to direct simulations that model individual
fractions of a treatment. Analysis shows that incorporation of the organ motion could lead to
changes in the dose prescribed for a treatment based on the Veff of the uninvolved liver. Comparison
of convolution-based calculations and direct simulation of various worst-case scenarios indicates
that a single convolution-based calculation is sufficient to predict the dose distribution for the
example treatment plan given. © 1999 American Association of Physicists in Medicine.
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Uncertainties in the target position in conformal radiotherapy
arise from daily setup uncertainties and organ motion. Setup
uncertainties can be reduced via immobilization techniques
and careful daily repositioning of the patient using portal
imaging and alignment tools.1,2 For treatment sites in the
abdomen, intratreatment organ motion occurs due to breath-
ing, and efforts are underway to minimize the resulting po-
sition uncertainties.3–10 Two primary approaches exist to ac-
count for the resulting uncertainties in the planned dose
distribution. The ‘‘traditional’’ approach measures or esti-
mates the extent of setup uncertainty and organ motion and
adds margins around a clinical tumor volume ~CTV! to form
a planning target volume ~PTV!. The dose is calculated on a
static patient model and prescribed to the PTV with the in-
tent that the CTV will almost always lie within the area
defined by the PTV. However, this margin expansion ap-
proach does not describe the effects of the uncertainties on
the normal tissues near the CTV. The second approach also
includes margins for error but incorporates the uncertainties
into the dose calculations, thereby giving more complete and
accurate information on the dose delivered to both the target
volume and the nearby normal tissues.
Methods based on a convolution of the static dose distri-
bution with a function ~generally Gaussian! representing the
distribution of uncertainties from setup and intertreatment
organ motion have been proposed for sites in the pelvis.11–15
The goal of the present work is to extend convolution-based
methods to incorporate uncertainties from intratreatment or-715 Med. Phys. 26 5, May 1999 0094-2405/99/265gan motion due to breathing into 3D dose calculations. In
this paper, we confirm the validity of this approach via com-
parisons to direct simulations for treatment of tumors in the
liver. Also, we retrospectively analyze the effects of the un-
certainties on the treatment plan and dose prescription with a
treatment protocol for liver disease used at the University of
Michigan.16–18
METHODS AND MATERIALS
The basic algorithm for convolving setup uncertainties
with a static dose distribution has been described
previously.11–15 We have extended the general convolution
of setup errors to include the effects of organ motion due to
breathing. Use of the convolution method assumes rigid
body motion. Several authors19–21 have noted that the motion
due to breathing of some organs in the abdomen, particularly
the liver, is predominantly ~though not exclusively! in the
superior–inferior ~SI! direction. This general convention is
supported by computed tomography ~CT! studies.3 Thus, we
have assumed for this study that the organ motion is one-
dimensional along the SI axis. This motion can be incorpo-
rated into a dose distribution using a convolution, as de-
scribed in Eq. ~1!. ~Although limited to one-dimensional
motion here for clarity, the formalism is readily applicable
for more complete rigid body motion using D¯ (r8)
5* D0(r82r8)pom(r8)dr8.)
D¯ ~x ,y ,z !5E D0~x ,y ,z2z8!pom~z8!dz8, ~1!
715/715/6/$15.00 © 1999 Am. Assoc. Phys. Med.
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x ,y ,z , D0(x ,y ,z2z8) is the original dose distribution at a
point x ,y ,z2z8, and pom(z8) represents the probability dis-
tribution function describing the organ motion due to breath-
ing along the superior–inferior ~SI! axis ~details below!.
The form of pom(z) was found by considering the nature
of the organ motion due to breathing. Unlike setup uncertain-
ties, the organ motion due to breathing is an intratreatment
motion. Davies21 found that the motion of the liver is well
correlated with the motion of the diaphragm. Balter et al.,
observed under fluoroscopy that the motion of the diaphragm
due to breathing is generally periodic but asymmetric, with
the majority of time spent at the exhale position, as shown in
Fig. 1.22 These results are similar to those reported by Kubo.6
Other studies have shown, however, that the period and am-
plitude of the motion due to breathing can vary, even over a
short period of time.7,23 Our current model assumes a fixed
period and amplitude of motion, where the values for the
period and amplitude are selected to represent an average
observed amplitude and period ~Fig. 1!.
Assuming a fixed period for the motion, the position of
the organ as a function of time can be parameterized. A
mathematical model that describes this type of motion is
z~ t !5z02b cos2n~pt/t2f!, ~2!
where z0 is the position at exhale, b is the extent ~amplitude!
of the motion, z02b is the position at inhale, t is the period
of breathing cycle, n is a parameter that determines general
shape ~steepness and flatness! of the model, and f is the
starting phase of the breathing cycle. For the example case
shown, we used a period for the breathing cycle t54.2 s, an
extent of motion b51.5 cm, and a value of n53.
Patients on the liver treatment protocol at the University
of Michigan ~UM! were CT-scanned at the exhale position.22
We used the relationship in Eq. ~2! along with the following
definitions to generate a probability distribution function
~PDF! for points in the liver being a distance, z, away from
the starting position at exhale ~for 12 a breathing cycle!.
pom(z)dz is the probability that a point lies between z and
FIG. 1. Position of diaphragm due to breathing seen in fluoroscopic studies
~triangles! and mathematical model of data ~solid line!.Medical Physics, Vol. 26, No. 5, May 1999z1dz and is equal to the fraction of the total time that a
point spends in the interval between t and t1dt
pom~z !dz5
dt
t/2 ,
~3!
pom~z !5
2
t
dt
dz .
We wish to express the PDF as a function of position
rather than a function of time, so Eq. ~2! is solved for t and
used in Eq. ~3!, yielding the following expression:
pom~z !5H nbpS z02zb D ~2n21 !/2n
3F12S z02zb D
1/nG1/2J 21 for z02b,z,z0 .
~4!
This PDF integrates to 1 over the interval z02b,z
,z0 , as desired ~and required for a probability distribution
function!, and is a function of the extent of motion b, and the
shaping parameter n, but not the beam-on time T or the start-
ing phase f.
Use of the PDF described in Eq. ~4! ~integrated over the
extent of motion from z02b to z0) in the convolution @Eq.
~1!# determines the dose distribution that would result from a
patient receiving an infinite number of fractions and being
treated over an infinite number of breathing cycles per frac-
tion. In reality, the patient is treated for a finite number of
fractions and a finite number of breathing cycles. The PDFs
representing the nature of motion for the same treatment time
T but different starting phases f differ from each other and
from the PDF generated using Eq. ~4!. A direct
simulation15,24 of each situation would more accurately ac-
count for the organ motion due to breathing. However, to
reflect an entire course of treatment consisting of many indi-
vidual fractions, a large number of simulations would need
to be performed. Hence, a single convolution calculation
would often be preferred in treatment planning applications.
We performed direct simulations of the breathing cycle for
individual treatments to determine how neglecting the start-
ing phase f and the treatment time T might affect the con-
volution calculation. Our procedure is described below.
1. As shown in Fig. 2, we discretized the organ position
as a function of time into 10 bins. The organ position in each
bin was computed from the time-weighted average of the
organ position in that bin.
2. The change in organ position was simulated in the
treatment planning system by moving the beams and iso-
center in a direction opposite the motion @i.e., only in the z
~SI! direction#.
3. The dose distribution was recalculated for each simu-
lated position.
4. We computed the probability pbi of finding the organ
in the ith bin based on the mathematical model of the organ
motion given in Eq. ~2!.
717 Lujan et al.: A method for incorporating organ motion 7175. Each calculation at a simulated position was weighted
by pbi .
6. Beam weights were adjusted by the ratio of tissue
phantom ratios to account for changes in SSD and calcula-
tion depth due to changes in the external contour.
7. Individual simulations were summed to form a com-
posite dose distribution using the treatment planning geom-
etry as a backdrop.
The calculated probability pbi of the organ residing in bin
i is a function of both the starting phase, f ~point in breath-
ing cycle when the treatment begins! and the treatment time,
T ~beam-on time!, pbi5pbi(f ,T). We computed pbi for one-
half of a breathing cycle ~exhale to inhale, f50! and will
henceforth refer to this probability as the global or standard
probability per bin, pgi . This is a discrete version of the PDF
that we can calculate using Eq. ~4!, which assumes that the
starting phase does not affect the probability of an organ
moving into a given position ~i.e., the treatment beam-on
time is equal to an integral number of symmetric half-cycles
of the breathing!.
We calculated pbi(f ,T) for treatment times ranging be-
tween 4 and 9 breathing cycles ~;8–20 s!. For each T, we
varied f over one complete breathing cycle ~from exhale to
exhale! and compared pbi(f ,T) to the global probabilities
pgi to determine how the probabilities varied as a function of
f and T.
For each beam in a treatment, ;100 monitor units ~M.U.!
are delivered at a rate of ;300 M.U./min. This leads to
beam-on times of ;20 s. We specifically examined a treat-
ment time of T5Ts59.45 s ~2.25 breathing cycles! for our
worst case simulations. This treatment time is shorter than
most of our expected treatment times but is on the correct
time scale for segmented radiation therapy treatment at UM,
which is delivered at 600 M.U./min ~;10 s beam-on time!.
Thus, we calculated pbi(f ,Ts) and determined the starting
phases, f j( j51 – 10), that resulted in maximum differences
for each of the 10 bins.
We simulated the organ motion for each of those starting
phases, f j , using the appropriate probability distribution,
pbi(f j ,Ts) in the direct simulation. These simulations rep-
FIG. 2. Organ position as a function of time discretized into 10 bins for one
half of a breathing cycle ~exhale to inhale!.Medical Physics, Vol. 26, No. 5, May 1999resent potential ~but highly unlikely! worst case scenarios, in
which each treatment would begin at the same starting phase
f j , and last for the same treatment time Ts , thus each treat-
ment fraction is synchronized to yield a probability distribu-
tion pbi(f j ,Ts) that is most different from the global prob-
ability used for the convolution.
For each of our simulations, we generated dose volume
histograms ~DVHs! for the CTV and the uninvolved liver.
From the DVH, we calculated the effective volume,
Veff ,25–27 for the uninvolved liver. We compared DVHs and
Veff values for all generated dose distributions.
The treatment planning geometry used for the simulation
presented here is shown in Fig. 3~a!. The gross tumor vol-
ume ~GTV! was located in the anterior–inferior region of the
liver. The resultant PTV was treated using a pair of axial
beams @RPO ~right-posterior-oblique!, LPO ~left-posterior-
oblique!# complimented by a wedged oblique off-axis beam
@right-anterior-superior-oblique ~RASO!#. The PTV was
completely covered by the 95% isodose surface.
For a reference simulation, we compared the dose distri-
bution calculated via the convolution method @Eq. ~1!# to the
static ~initial treatment plan! dose distribution. Next, we
compared the convolved dose distribution to the dose distri-
bution calculated via direct simulation using the global PDF.
We then found the difference between the dose distribution
calculated using the global PDF and the dose distributions
calculated from the worst case scenarios.
RESULTS
A dose difference display between the convolved dose
distribution and the static dose distribution is shown in Fig.
3~b!. For this particular treatment plan and tumor location
~recall, CT scan was obtained at exhale!, we could expect the
motion due to breathing to cause regions superior to the su-
perior beam edges to move into the beam and regions supe-
rior to the inferior beam edges to move out of the beam
@observed by comparison of Figs. 3~a! and 3~b!#. Differences
up to 26% are calculated between the convolved dose distri-
bution and the static dose distribution in regions outside of
the CTV.
The dose distribution including motion due to breathing
shows that the planned dose is delivered to the CTV, indi-
cating that the margins chosen for the PTV were sufficient.
Examination of the DVH of the uninvolved liver agree with
our observations for this plan. For this tumor location and
treatment plan, organ motion will result in an increase in the
mean dose delivered to normal liver compared with the dose
calculated for the static treatment plan. This also translates
into an increase in Veff for the convolved dose distribution,
relative to the static plan, sufficient to suggest a change in
the prescription dose assigned for this treatment plan to
maintain a fixed level of toxicity.18,26
Figure 4 shows the probability of being in bin 10, pb10 ,
for three different treatment times. As can be seen, the prob-
abilities for bin 10 vary periodically about the global prob-
ability ~as expected, based on the nature of the motion itself!
as the starting phase, f varies across the breathing cycle. In
718 Lujan et al.: A method for incorporating organ motion 718FIG. 3. ~a! Example three-field liver tumor treatment plan comprising a pair of axial beams, right-posterior-oblique ~RPO! and left-posterior-oblique ~LPO!,
and a wedged oblique off-axis beam, right-anterior-superior-oblique ~RASO!. PTV volume includes a superior margin of 0.3 cm and an inferior margin of 1.5
cm for breathing as well as a uniform 0.5 cm margin for setup uncertainties, all with respect to the CTV ~black contour!. ~b! Dose difference display between
convolved dose distribution ~including organ motion! and static dose distribution. Regions where the convolved dose distribution receives more dose than the
static dose distribution would predict are indicated as D¯ .D0 . Regions where the convolved dose distribution receives less dose than predicted by the static
dose distribution are indicated as D¯ ,D0 .addition, as the treatment time T increases, the maximum
differences between pbi and pgi decrease. Cumulative DVHs
for the uninvolved liver generated from the dose distribu-
tions calculated using the global probability distribution and
FIG. 4. pb10 for three treatment times, T, as a function of the starting phase,
f. Solid line: T159.975 s, dashed line: T2514.175 s, hatched line: T3
518.357 s, horizontal line: pg1050.477.Medical Physics, Vol. 26, No. 5, May 1999the worst case scenario PDFs were nearly identical for each
scenario. The dose distributions themselves agreed to within
62% for ;98% of the calculation volume ~for a single worst
case simulation!. The Veff values calculated for the worst
case scenarios differed from the Veff from the global PDF
simulation by less than 0.35%; quite insufficient to cause
consideration of changes in prescription dose.
The dose distribution calculated using the convolution-
based method and the dose distribution calculated via a di-
rect simulation using the global PDF were nearly identical,
with dose differences of less than 62% to over 98% of the
uninvolved liver volume. The Veff values calculated via each
method differed insignificantly ~'0.2%!.
DISCUSSION
Intratreatment organ motion due to breathing can lead to
erroneous prediction of the dose delivered to a patient when
a static computed tomography ~CT! scan of a patient is used
for treatment planning dose calculations. Though the ex-
ample shown is specific to a particular treatment planning
geometry, the importance of incorporating the organ motion
due to breathing in the dose calculation is clear. That is,
719 Lujan et al.: A method for incorporating organ motion 719including the effects of breathing on the calculation of dose
to these normal tissues ~liver! can lead to changes in pre-
scription dose in our protocol setting.
We have also compared direct simulations using a global
PDF to the convolution calculation and found good agree-
ment between the dose distributions generated via the two
procedures. This was expected, because the global PDF is a
discrete version of the PDF used in the convolution calcula-
tion.
This convolution-based procedure and the direct simula-
tion using the global PDF yield dose distributions resulting
from the patient receiving an infinite number of fractions, or
equivalently, being treated over an infinite number of breath-
ing cycles. The PDF generated for the convolution calcula-
tion neglects the effects of the finite beam-on time and the
starting phase of the breathing cycle. However, we hypoth-
esized that the phase differences would cancel out in a simu-
lation of a treatment because there are sufficiently many frac-
tions for each treatment. This was verified by considering
potential worst case scenarios in the simulations. We can
expect that the starting phase, unless monitored, will vary
randomly for each fraction. Hence, the differences for each
bin will cancel out. This means that we can simulate the
organ motion due to breathing using our simple global prob-
ability in a direct simulation or convolution-based calcula-
tion and do not need to simulate each fraction to model the
organ motion due to breathing.
As noted above, studies have shown that the period and
amplitude of the motion due to breathing can vary.7,23 Our
current model assumes a fixed period and amplitude of mo-
tion chosen to represent an average observed amplitude and
period, and thus an average expected dose distribution in-
cluding the effects of breathing. As with the starting phase of
breathing, the unexpected variations in period and amplitude
should average out over the course of a treatment.
The convolution calculation is applied to the entire dose
grid. However, some structures in the grid ~e.g., the spinal
cord! may not move according to the observations in Fig. 1.
The dose to such structures must be analyzed using other
methods or different PDFs as the simulated dose distribution
calculated using the above procedure only represents dose to
structures that move according to those observations.
Our results are specific for the patient geometry and treat-
ment plan shown. However, for standard axial treatment
plans in the abdomen, we would expect the general results to
apply ~i.e., regions superior to the superior beam edges move
into the beam and regions superior to the inferior beam edges
will move out of the beam!. The specific magnitude of the
changes will depend on the actual treatment plan.
The convolution-based procedure given by Eq. ~1! will
apply in regions where the dose distribution is invariant un-
der small changes in the setup orientation. In regions where
this is not true ~such as the lung-tissue interface and the
surface-patient interface!, careful direct simulation of the
motion will provide more accurate computation of the aver-
age dose distribution including uncertainties. Also, rigid
body motion assumes no change in the patient external con-
tour and no organ deformation. Patient breathing can resultMedical Physics, Vol. 26, No. 5, May 1999in small ~typically ,1 cm! changes in beam pathlength.
These changes can lead to small changes in dose for single
beams.3,21
Further, as the nature of the organ motion is better under-
stood and parameterized, confirmation of a convolution-
based procedure such as in Eq. ~1!, will require a more com-
plete direct simulation which includes the effects of changes
in the patient external contour and any organ deformation
which may occur. In addition, a more complex PDF may be
required to model the more complex motion. We have pre-
sented a basic framework from which additional study may
occur.
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